SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3086IMGN 19% on halting lung cancer trial.nigel bates-11/6/2013
3085SQNM down 24% Ariosa says court invalidates Sequenom patent finance.yahoo.comRMP-10/31/2013
3084ARIA down 40% on pulling Iclusig from market.IRWIN JAMES FRANKEL-10/31/2013
3083Ziopharm (ZIOP) off 17% on a financing. As you suggested, tank needed filling. tuck-10/23/2013
3082PSDV down about 20% - the FDA rejected ILUVIEN again ..... 6:35AM pSivida repJohn McCarthy-10/18/2013
3081ARIA off over 30% on ending EPIC trialIRWIN JAMES FRANKEL-10/18/2013
3080...fish oil whiffs with the FDA. With the FDA panel. There's a slim but non-DewDiligence_on_SI-10/17/2013
3079AMRN 60%, as fish oil whiffs with the FDA. BEDMINSTER, N.J. and DUBLIN, Irelandnigel bates-10/17/2013
3078CNDO -67% BURLINGTON, MA ( TheStreet) -- Swallowing the tiny live eggs of pig patnsaf-10/14/2013
3077ARIA down another 15% to 4.60IRWIN JAMES FRANKEL-10/11/2013
3076Not necessarily overdone, IMO: siliconinvestor.comDewDiligence_on_SI-10/9/2013
3075I had some shares of ARIA, and I am not that clued in on the programs, nor on thBiotech Jim-10/9/2013
3074ARIA at 4 This is a rare fall - huge. Overdone?IRWIN JAMES FRANKEL-10/9/2013
3073Now a volatility trading pause in ARIA. That is the LUDP trading halt symbol.Biotech Jim-10/9/2013
3072ARIA down hard, over 70% on iclusig tox issues and study pauseIRWIN JAMES FRANKEL-10/9/2013
3071CytRx (CYTR) joining the firesale ranks, off 16%. No news, but arguably a recentuck-10/8/2013
3070In the case of IDIX, there was bearish, company-specific news involving JNJ and DewDiligence_on_SI-10/8/2013
3069High flyers acad and gern, 16% and 17% respectively. idix too, 22%. Sector cscaram(o)uche-10/8/2013
3068ATOS (in AH session) on "voluntary" recall of MASCT. Longs can cheer DewDiligence_on_SI-10/5/2013
3067Nektar Therapeutics (NKTR), a developer of drugs for pain and cancer, sank the mtnsaf-9/27/2013
3066ACHN almost cut in half in AH trading. After Hours Volume: After HourIan@SI-9/27/2013
3065NBIX, down some 30% AH Given the results at the high dose, there would seem to tom pope-9/9/2013
3064odd that folks expected so much from this point of the study...the high dose seemopgcw-9/3/2013
3063CYTK: Sept. 3, 2013 /PRNewswire/ -- Amgen (AMGN) and Cytokinetics Incorporated nigel bates-9/3/2013
3062VICL more than cut in half: Vical Incorporated ( VICL) today announced top-linenigel bates-8/12/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News